Your browser doesn't support javascript.
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Serazin, Nathan A; Edem, Bassey; Williams, Sarah R; Ortiz, Justin R; Kawade, Anand; Das, Manoj Kumar; Subelj, Maja; Edwards, Kathryn M; Parida, Shreemanta K; Wartel, T Anh; Munoz, Flor M; Bastero, Patricia.
  • Serazin NA; Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Edem B; Department of Vaccines and Immunity, Medical Research Council the Gambia Unit at the London School of Hygiene and Tropical Medicine, UK.
  • Williams SR; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Ortiz JR; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Kawade A; King Edward Memorial Hospital Research Centre, Vadu Rural Health Program Pune, India.
  • Das MK; The INCLEN Trust International, New Delhi, India.
  • Subelj M; National Institute of Public Health, University of Ljubljana, Slovenia.
  • Edwards KM; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Parida SK; CureVac AG, Frankfurt, Germany.
  • Wartel TA; International Vaccine Institute, Seoul, Republic of Korea.
  • Munoz FM; Departments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Bastero P; Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. Electronic address: pxbaster@texaschildrens.org.
Vaccine ; 39(22): 3028-3036, 2021 05 21.
Article in English | MEDLINE | ID: covidwho-1051979
ABSTRACT
This is a Brighton Collaboration Case Definition of the term "Acute Respiratory Distress Syndrome - ARDS" to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Diagnostic study / Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article Affiliation country: J.vaccine.2021.01.053

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Diagnostic study / Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article Affiliation country: J.vaccine.2021.01.053